Literature DB >> 856089

Studies with an artificial endocrine pancreas.

A M Albisser, B S Leibel, B Zinman, F T Murray, W Zingg, C K Botz, A Denoga, E B Marliss.   

Abstract

Short-term studies with an artificial endocrine pancreas have provided insights into the pathophysiology of diabetes and demonstrated the ability of such a system to restore and maintain glucose homeostasis in human subjects given either their usual diet, a 50 gm oral glucose tolerance test, or a moderate level of physical exercise. Animals were used to demonstrate that a peripheral route of insulin delivery by the artificial pancreas is equivalent to the portal route.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 856089

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  5 in total

Review 1.  Status of pancreatic transplants and mechanical devices for blood glucose control in diabetes.

Authors:  J V Santiago; N H White
Journal:  Ann Biomed Eng       Date:  1980       Impact factor: 3.934

2.  Continuous blood glucose analysis in vitro and in vivo.

Authors:  A M Albisser; J Ellman; A Hanna; Y Goriya; H Minuk
Journal:  Diabetologia       Date:  1978-10       Impact factor: 10.122

3.  Hypercomplex models of insulin and glucose dynamics: do they predict experimental results?

Authors:  A M Albisser; Y Yamasaki; H Broekhuyse; J Tiran
Journal:  Ann Biomed Eng       Date:  1980       Impact factor: 3.934

4.  Blood glucose regulation using an open-loop insulin delivery system in pancreatectomized dogs given glucose infusions. I. Portal square waves.

Authors:  A M Albisser; C K Botz; B S Leibel
Journal:  Diabetologia       Date:  1979-02       Impact factor: 10.122

5.  The metabolic and hormonal response to acute normoglycaemia in type 1 (insulin-dependent) diabetes: studies with a glucose controlled insulin infusion system (artificial endocrine pancreas).

Authors:  R Nosadini; G A Noy; M Nattrass; K G Alberti; D G Johnston; P D Home; H Orskov
Journal:  Diabetologia       Date:  1982-09       Impact factor: 10.122

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.